Gaspar, Nathalie <br/><br/>
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  01 2018 
 - 57-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2017.09.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Diphosphonates--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>France<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Imidazoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Methotrexate--administration & dosage<br/>Neutropenia--chemically induced<br/>Osteosarcoma--drug therapy<br/>Young Adult<br/>Zoledronic Acid